- Home
- CTNM vs ABSI Comparison
CTNM vs ABSI Comparison
Compare CTNM & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- ABSI
- Stock Information
- Founded
- CTNM 2009
- ABSI 2011
- Country
- CTNM United States
- ABSI United States
- Employees
- CTNM N/A
- ABSI N/A
- Industry
- CTNM
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CTNM
- ABSI Health Care
- Exchange
- CTNM Nasdaq
- ABSI Nasdaq
- Market Cap
- CTNM 377.6M
- ABSI 318.2M
- IPO Year
- CTNM 2024
- ABSI 2021
- Fundamental
- Price
- CTNM $11.28
- ABSI $3.22
- Analyst Decision
- CTNM Strong Buy
- ABSI Strong Buy
- Analyst Count
- CTNM 4
- ABSI 6
- Target Price
- CTNM $29.25
- ABSI $8.50
- AVG Volume (30 Days)
- CTNM 135.4K
- ABSI 5.7M
- Earning Date
- CTNM 02-16-2025
- ABSI 11-12-2024
- Dividend Yield
- CTNM N/A
- ABSI N/A
- EPS Growth
- CTNM N/A
- ABSI N/A
- EPS
- CTNM N/A
- ABSI N/A
- Revenue
- CTNM N/A
- ABSI $4,207,000.00
- Revenue This Year
- CTNM N/A
- ABSI $8.57
- Revenue Next Year
- CTNM N/A
- ABSI $169.72
- P/E Ratio
- CTNM N/A
- ABSI N/A
- Revenue Growth
- CTNM N/A
- ABSI N/A
- 52 Week Low
- CTNM $11.38
- ABSI $2.45
- 52 Week High
- CTNM $22.00
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- ABSI 53.69
- Support Level
- CTNM N/A
- ABSI $2.66
- Resistance Level
- CTNM N/A
- ABSI $2.97
- Average True Range (ATR)
- CTNM 0.00
- ABSI 0.35
- MACD
- CTNM 0.00
- ABSI 0.02
- Stochastic Oscillator
- CTNM 0.00
- ABSI 40.30
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.